The global healthcare sector is intensifying its response to one of the most significant threats to public health: Extensively Drug-Resistant Tuberculosis (XDR-TB) Market As antibiotic resistance evolves, the market for specialized treatment regimens is shifting from prolonged, toxic injectable therapies toward shorter, all-oral, and highly effective curative programs. https://www.databridgemarketresearch.com/